If the guidelines for data sharing are not adhered to by providers, then all the work that has gone into revising this regulation will have been for nothing. But the road to compliance doesn’t have to be overwhelming. Here are three essential steps for healthcare leaders in navigating the soon-to-be Part 2 landscape. The post…
[Sponsored] In a webinar sponsored by Jotform, scheduled for Wednesday March 5 at 1pm ET, panelists will discuss how health tech vendors and healthcare practices approach data automation and how they can collaborate effectively. The post Using Automation to Streamline Healthcare Practice Workflows and Maximize Staff Effectiveness appeared first on MedCity News.
Regulators will have their work cut out for them under a new administration that has expressed an anti-regulatory preference. Republicans next year will control the White House, Senate and House. What will it all mean for pharmacy leaders? The post Some of the Biggest Healthcare Stories from 2024 Involved Pharmacy. What’s Next in 2025? appeared…
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley. The post “Precision Med Has Evolved as Badly As I Expected” And OtherTakeaways From Former FDA Commissioner At PMWC appeared first…
Novo Nordisk’s monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity. The post Oral Metabolic…
Little Otter’s $9.5 million fundraise included participation from Pivotal Ventures, Torch Capital, Springbank, CRV, Next Legacy, G9, Gratitude Railroad and Carrie Walton Penner’s Fiore Ventures. The company has raised more than $36 million to date. The post Little Otter Raises $9.5M for Family Mental Health appeared first on MedCity News.
It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures. The post Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry appeared first on MedCity News.
While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows. The post Balancing Innovation and Risk in Healthtech appeared first on MedCity News.
[Sponsored] In an interview, Redox CEO Trip Hofer shared why the company is well-positioned to facilitate the push for the nationwide exchange of electronic health information facilitated by the TEFCA framework. The post How Redox is Future-Proofing Healthcare Data as Interoperability Standards Evolve appeared first on MedCity News.
Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine to manage “off” periods experienced by Parkinson’s disease patients. Approval of Onapgo comes after the FDA twice turned back applications for the drug/device combination product. The post Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval appeared first on MedCity News.